{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:18:59Z","timestamp":1762917539823},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s40272-014-0087-z","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T02:43:34Z","timestamp":1409107414000},"page":"417-423","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Statin Use in Australian Children: A Retrospective Audit of Four Pediatric Hospitals"],"prefix":"10.1007","volume":"16","author":[{"given":"Ingrid C.","family":"Gelissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huy Long","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren K.","family":"Tiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Moles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,28]]},"reference":[{"key":"87_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mcna.2011.11.004","volume":"96","author":"HR Superko","year":"2012","unstructured":"Superko HR, Momary KM, Li Y. Statins personalized. Med Clin North Am. 2012;96:123\u201339.","journal-title":"Med Clin North Am"},{"key":"87_CR2","unstructured":"Data from http:\/\/www.pbs.gov.au\/info\/statistics\/asm\/asm-2010 ."},{"key":"87_CR3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/HCO.0b013e32836429e6","volume":"28","author":"CM Minder","year":"2013","unstructured":"Minder CM, Blumenthal RS, Blaha MJ. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks. Curr Opin Cardiol. 2013;28:554\u201360.","journal-title":"Curr Opin Cardiol"},{"key":"87_CR4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","volume":"106","author":"RC Pasternak","year":"2002","unstructured":"Pasternak RC, et al. ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins. Circulation. 2002;106:1024\u20138.","journal-title":"Circulation"},{"key":"87_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/11319490-000000000-00000","volume":"33","author":"AS Wierzbicki","year":"2010","unstructured":"Wierzbicki AS, Viljoen A. Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice. Drug Saf. 2010;33:115\u201325.","journal-title":"Drug Saf"},{"key":"87_CR6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","volume":"223","author":"FJ Raal","year":"2012","unstructured":"Raal FJ, Santos RD. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis. 2012;223:262\u20138.","journal-title":"Atherosclerosis"},{"key":"87_CR7","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478\u201390.","journal-title":"Eur Heart J."},{"key":"87_CR8","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.113.002411","volume":"128","author":"BW McCrindle","year":"2013","unstructured":"McCrindle BW, Tyrrell PN, Kavey RE. Will obesity increase the proportion of children and adolescents recommended for a statin? Circulation. 2013;128:2162\u20135.","journal-title":"Circulation"},{"key":"87_CR9","doi-asserted-by":"crossref","first-page":"E263","DOI":"10.1111\/jpc.12036","volume":"49","author":"AC Martin","year":"2013","unstructured":"Martin AC, Coakley J, Forbes DA, Sullivan DR, Watts GF. Familial hypercholesterolaemia in children and adolescents: a new paediatric model of care. J Paediatr Child Health. 2013;49:E263\u201372.","journal-title":"J Paediatr Child Health"},{"key":"87_CR10","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","volume":"5","author":"SR Daniels","year":"2011","unstructured":"Daniels SR, Gidding SS, de Ferranti SD. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5:S30\u20137.","journal-title":"J Clin Lipidol"},{"key":"87_CR11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","volume":"218","author":"OS Descamps","year":"2011","unstructured":"Descamps OS, et al. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis. 2011;218:272\u201380.","journal-title":"Atherosclerosis"},{"key":"87_CR12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2165\/11632810-000000000-00000","volume":"72","author":"MJ Braamskamp","year":"2012","unstructured":"Braamskamp MJ, Wijburg FA, Wiegman A. Drug therapy of hypercholesterolaemia in children and adolescents. Drugs. 2012;72:759\u201372.","journal-title":"Drugs"},{"key":"87_CR13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cld.2012.12.004","volume":"17","author":"JL Hartley","year":"2013","unstructured":"Hartley JL, Gissen P, Kelly DA. Alagille syndrome and other hereditary causes of cholestasis. Clin Liver Dis. 2013;17:279\u2013300.","journal-title":"Clin Liver Dis"},{"key":"87_CR14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/apa.12280","volume":"102","author":"N Lamaida","year":"2013","unstructured":"Lamaida N, Capuano E, Pinto L, Capuano R, Capuano V. The safety of statins in children. Acta Paediatr. 2013;102:857\u201362.","journal-title":"Acta Paediatr"},{"key":"87_CR15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2012.10.032","volume":"226","author":"A Vuorio","year":"2013","unstructured":"Vuorio A, Docherty KF, Humphries SE, Kuoppala J, Kovanen PT. Statin treatment of children with familial hypercholesterolemia\u2014trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus? Atherosclerosis. 2013;226:315\u201320.","journal-title":"Atherosclerosis"},{"key":"87_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archpediatrics.2009.5","volume":"163","author":"JN Liberman","year":"2009","unstructured":"Liberman JN, Berger JE, Lewis M. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch Pediatr Adolesc Med. 2009;163:357\u201364.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"87_CR17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1399-3046.2007.00827.x","volume":"12","author":"C Chin","year":"2008","unstructured":"Chin C, Lukito SS, Shek J, Bernstein D, Perry SB. Prevention of pediatric graft coronary artery disease: atorvastatin. Pediatr Transplant. 2008;12:442\u20136.","journal-title":"Pediatr Transplant"},{"key":"87_CR18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1053-2498(02)00455-2","volume":"21","author":"C Chin","year":"2002","unstructured":"Chin C, Gamberg P, Miller J, Luikart H, Bernstein D. Efficacy and safety of atorvastatin after pediatric heart transplantation. J Heart Lung Transplant. 2002;21:1213\u20137.","journal-title":"J Heart Lung Transplant"},{"key":"87_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","volume":"157","author":"A Upadhyay","year":"2012","unstructured":"Upadhyay A, et al. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;157:251\u201362.","journal-title":"Ann Intern Med"},{"key":"87_CR20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00467-011-1872-3","volume":"27","author":"K Tullus","year":"2012","unstructured":"Tullus K. Dyslipidemia in children with CKD: should we treat with statins? Pediatr Nephrol. 2012;27:357\u201362.","journal-title":"Pediatr Nephrol"},{"key":"87_CR21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2169\/internalmedicine.50.4484","volume":"50","author":"Y Oshima","year":"2011","unstructured":"Oshima Y. Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the US Food and Drug Administration. Intern Med. 2011;50:845\u201353.","journal-title":"Intern Med"},{"key":"87_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1399-3046.2003.02048.x","volume":"7","author":"E Argent","year":"2003","unstructured":"Argent E, Kainer G, Aitken M, Rosenberg AR, Mackie FE. Atorvastatin treatment for hyperlipidemia in pediatric renal transplant recipients. Pediatr Transplant. 2003;7:38\u201342.","journal-title":"Pediatr Transplant"},{"key":"87_CR23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacl.2013.06.010","volume":"7","author":"DM Kusters","year":"2013","unstructured":"Kusters DM, et al. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia. J Clin Lipidol. 2013;7:408\u201313.","journal-title":"J Clin Lipidol"},{"key":"87_CR24","first-page":"CD006401","volume":"7","author":"A Vuorio","year":"2014","unstructured":"Vuorio A, et al. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev. 2014;7:CD006401.","journal-title":"Cochrane Database Syst Rev."},{"key":"87_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/11591650-000000000-00000","volume":"13","author":"V Carreau","year":"2011","unstructured":"Carreau V, Girardet JP, Bruckert E. Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability. Paediatr Drugs. 2011;13:267\u201375.","journal-title":"Paediatr Drugs"},{"key":"87_CR26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.106.671016","volume":"116","author":"J Rodenburg","year":"2007","unstructured":"Rodenburg J, et al. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation. 2007;116:664\u20138.","journal-title":"Circulation"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-014-0087-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0087-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:44:46Z","timestamp":1559490286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-014-0087-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,28]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1007\/s40272-014-0087-z","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,28]]}}}